About SleepApnea.org

The American Sleep Apnea Association (ASAA) launched SleepApnea.org in 2010. Since that time, the site has achieved a number of milestones. OneCare Media acquired SleepApnea.org from the ASAA in April 2022, and will continue the original mission of educating the public about sleep apnea and its treatments. The ASAA can now be reached at SleepHealth.org.

OneCare Media is currently building a team dedicated to SleepApnea.org. Our goal is to expand the site’s resources and publish content that will help our readers choose safe, high-quality CPAP products. We also plan to optimize the health information on our site with experienced medical reviewers.

Thank you for your continued readership during this transitional phase for SleepApnea.org. Check back in the weeks and months ahead to see the changes we’ve implemented.

Medical Disclaimer

The purpose of this site is to educate readers about sleep apnea. Our content is not a substitute for medical care. If you or a loved one are experiencing sleep apnea symptoms or you’d like to learn about treatment options, please consult with a licensed physician who is qualified to make medical recommendations.

Meet our Team

Martinique Edwards - Staff Writer

Martinique Edwards - Staff Writer

Martinique writes content focused on sleep health, science, and trends. She graduated from the University of Georgia with a bachelor’s degree in Ecology and master’s degree in Environmental Health and has research experience in environmental microbiology and aquatic science. Martinique loves to view the world through an ecological lens, where everything is interconnected. In her free time, she enjoys outdoor activities such as running and parkour.

Tochukwu Ikpeze - Staff Writer

Tochukwu Ikpeze - Staff Writer

Tochukwu grew up in New York and has a passion for creative and scientific writing. Tochukwu holds an undergraduate degree in Biology and Psychology, a Master’s degree in Biomedical Science, and a Medical Degree as well. In his free time, Tochukwu enjoys reading, learning, exploring various topics pertaining to the human condition and conveying that information to the public through writing.

Ashley Wood - Staff Writer

Ashley Wood - Staff Writer

Ashley is a registered nurse with over 15 years of experience and holds a bachelor’s degree in nursing. It is no surprise she likes writing about health information that encourages and enables others to live their healthiest life possible. Ashley enjoys spending time with her family, reading, hiking, and photography during her free time.

Gerard Meskill, MD FAASM - Medical Reviewer

Gerard Meskill, MD FAASM - Medical Reviewer

Gerard J. Meskill, MD is board certified in both neurology and sleep medicine, and he is the founder and CEO of Tricoastal Narcolepsy and Sleep Disorders Center. The "Tricoastal" moniker references his background: he completed neurology residency on the East Coast at Long Island Jewish Medical Center – where he served as chief resident, sleep fellowship on the West Coast at Stanford University, and he now practices sleep medicine and neurology on the Gulf Coast in the greater Houston, Texas area.

In the sleep world, he is known for expertise in the treatment of narcolepsy, obstructive sleep apnea (OSA), and insomnia. He is published in peer-reviewed journals and texts, as well as online media. He has served as principal investigator in clinical research trials focused on narcolepsy and OSA. He regularly serves on narcolepsy treatment advisory boards and founded A.W.A.K.E. Greater Houston, a support group for individuals afflicted with narcolepsy and other sleep disorders that works in partnership with the Narcolepsy Network and the American Sleep Apnea Association. He has been recognized by Texas Monthly magazine as one of Texas’s Super Doctors Rising Stars (2018-22).

Dr. Meskill’s professional passion is to improve the lives of patients suffering from disorders of central hypersomnia, such as narcolepsy and idiopathic hypersomnia. From 2019-20, he was the principal investigator of the Houston arm of the Pitolisant Expanded Access Clinical Evaluation (PEACE) program. During PEACE, he discovered that narcolepsy type 1 patients refractory to standard-of-care agents at that time had a 75 percent improvement in cataplexy with pitolisant treatment. Dr. Meskill was invited by Harmony Biosciences to travel to the F.D.A., and on December 12, 2019, he served as their U.S.-based clinical expert on pitolisant’s role in treating cataplexy. That meeting ultimately led to the F.D.A.’s decision to approve pitolisant (Wakix) to treat cataplexy in adults with narcolepsy. Still, the “bread and butter” of Dr. Meskill’s practice is OSA and sleep-disordered breathing.

With Drs. Guilleminault and Arora, Dr. Meskill co-authored a meta-analysis on inspiratory flow limitation (IFL), a non-invasive measure of increased upper airway resistance during sleep to diagnose upper airway resistance syndrome (UARS). Prior to utilizing nasal pressure transducer flow signal to measure IFL, patients with suspected UARS would undergo an invasive and uncomfortable procedure to have a Dobhoff feeding tube inserted intranasally and down into the mid-level of the esophagus. Called “esophageal manometry” (Pes), this tube then would remain in the esophagus for the duration of the overnight sleep study. With IFL monitoring, this no longer is necessary.

Howard Hoffman, DDS - Medical Reviewer

Howard Hoffman, DDS - Medical Reviewer

Dr. Howard J Hoffman was born and grew up in New York. After attending the Ohio State University -B.S. 1970, he attended The University of Maryland School of Dentistry, earning his DDS degree in 1974. Dr. Hoffman served 2 years in the U.S. Public Health Service in Guam from 1974-1976. Upon returning to the continental U.S., he opened a private dental practice in North Miami, Fl, and relocated to Aventura in 1997. He began his studies in Implant Dentistry in the mid-90s, including two 18-month programs, first with the American Academy of Implant Dentistry, followed by a second at Harvard University.

In 1997, Dr. Hoffman was diagnosed with Severe Obstructive Sleep Apnea (OS) and began using a CPAP machine, which he could not tolerate. It was then that he learned about Dental Sleep Medicine and treatment of OSA using Dental Oral Appliance Therapy (OAT) and started using an Oral Appliance himself, with great success. Dr. Hoffman studied Sedation Dentistry at Montefiore Hospital in the Bronx, N.Y., and incorporated sedation into his general reconstructive dental practice. This allowed truly apprehensive, as well as time-constrained patients, to achieve comprehensive cosmetic and implant reconstructive dentistry in a few visits, rather than what could have taken multiple visits over a lengthy period of time. In 1997 he started treating Sleep Apnea patients who desired an alternative to CPAP therapy. In 2019, he limited his practice to Dental Sleep Medicine and Temporomandibular Joint Disorders.

Dr. Hoffman mentors dentists just starting out in Dental Sleep Medicine. He is available for lectures to groups of dentists, physicians, and local community organizations. He has been a member of many organizations through his 50 years in organized dentistry, including the American Dental Association, Florida Dental Association, Academy of General Dentistry, American Academy of Cosmetic Dentistry, and a charter member of the Fl Acad of Cosmetic Dentistry. He is a member of the American Academy of Sleep Medicine, the American Academy of Dental Sleep Medicine, the American Academy of Craniomandibular Dysfunction, and the American Academy of Physiologic Medicine and dentistry.

Dr. Hoffman has developed the Sleep is Life (™) multidisciplinary Collaborative Program for treating Sleep Apnea and TMD, incorporating the Elite Sleep Quality of Life Sleep Triangle(™) philosophy. This focuses on a wholesome balance of Structure- Biochemical- Emotional components, of which Sleep is a great influencer and vise versa.